Tci Wealth Advisors, Inc. Gilead Sciences, Inc. Transaction History

Tci Wealth Advisors, Inc.

$1.12 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$77.31 - $88.08 $3,556 - $4,051	-46 Reduced 3.87%	1,143 $94,000
Q4 2022 Feb 06, 2023	BUY	$62.32 - $89.47 $3,676 - $5,278	59 Added 5.22%	1,189 $102,000
Q3 2022 Nov 08, 2022	SELL	$59.54 - $68.01 $416 - $476	-7 Reduced 0.62%	1,130 $70,000
Q2 2022 Jul 19, 2022	BUY	$57.72 - $65.01 $25,223 - $28,409	437 Added 62.43%	1,137 $70,000
Q1 2022 Apr 29, 2022	SELL	$57.92 - $72.58 $15,754 - $19,741	-272 Reduced 27.98%	700 $41,000
Q4 2021 Jan 24, 2022	BUY	$64.88 - $73.64 $16,739 - $18,999	258 Added 36.13%	972 $71,000
Q3 2021 Oct 29, 2021	BUY	$67.69 - $73.03 $1,963 - $2,117	29 Added 4.23%	714 $50,000
Q2 2021 Aug 02, 2021	BUY	$63.47 - $69.35 $3,173 - $3,467	50 Added 7.87%	685 $47,000
Q1 2021 Apr 29, 2021	SELL	$60.0 - $68.46 $11,520 - $13,144	-192 Reduced 23.22%	635 $41,000
Q4 2020 Jan 21, 2021	BUY	$56.65 - $64.55 $906 - $1,032	16 Added 1.97%	827 $48,000
Q3 2020 Oct 20, 2020	SELL	$62.1 - $78.08 $869 - $1,093	-14 Reduced 1.7%	811 $51,000
Q2 2020 Jul 20, 2020	BUY	$72.34 - $84.0 $13,816 - $16,044	191 Added 30.13%	825 $63,000
Q1 2020 Apr 14, 2020	SELL	$62.63 - $80.22 $7,327 - $9,385	-117 Reduced 15.58%	634 $47,000
Q4 2019 Jan 27, 2020	BUY	$61.62 - $67.78 $308 - $338	5 Added 0.67%	751 $49,000
Q3 2019 Oct 17, 2019	SELL	$62.51 - $69.0 $3,750 - $4,140	-60 Reduced 7.44%	746 $47,000
Q2 2019 Jul 23, 2019	SELL	$61.87 - $69.38 $3,588 - $4,024	-58 Reduced 6.71%	806 $54,000
Q1 2019 Apr 11, 2019	BUY	$62.53 - $70.05 $6,065 - $6,794	97 Added 12.65%	864 $56,000
Q4 2018 Jan 17, 2019	SELL	$60.54 - $79.0 $605 - $790	-10 Reduced 1.29%	767 $48,000
Q3 2018 Nov 02, 2018	SELL	$71.28 - $78.92 $16,964 - $18,782	-238 Reduced 23.45%	777 $60,000
Q2 2018 Jul 27, 2018	SELL	$64.88 - $75.68 $454 - $529	-7 Reduced 0.68%	1,015 $72,000
Q1 2018 Apr 30, 2018	SELL	$72.84 - $88.8 $1,383 - $1,687	-19 Reduced 1.83%	1,022 $77,000
Q4 2017 Feb 01, 2018	SELL	$71.15 - $83.52 $213 - $250	-3 Reduced 0.29%	1,041 $75,000
Q3 2017 Oct 24, 2017	SELL	$72.11 - $85.47 $15,647 - $18,546	-217 Reduced 17.21%	1,044 $85,000
Q2 2017 Aug 10, 2017	BUY	N/A	1,261	1,261 $89,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.

Account